ST. PAUL, Minn. -- Ecolab Inc. announced today that it has purchased Shield Medicare Ltd., a leading European developer, manufacturer and marketer of contamination control products used in pharmaceutical, medical device and hospital clean rooms. It has sales of approximately $19 million. No further details regarding the transaction were announced.
Douglas M. Baker, Jr., Ecolab's chairman, president, and CEO, commented, "With its established position in the fast-growing clean room market, Shield will significantly enhance our European offering in healthcare and provide further product breadth as we work to help customers better meet rapidly increasing standards in pharmaceutical and medical device manufacturing processes. Further, the similarities between our two companies' direct sales and service approach, emphasis on customer service and focused product innovation should result in a seamless integration and bolster our Circle the Customer growth prospects in the healthcare infection control market."
With 2005 sales of $4.5 billion, Ecolab is a leading global developer and marketer of premium cleaning, sanitizing, pest elimination, maintenance and repair products for the hospitality, foodservice, healthcare, and industrial markets.
Source: Ecolab Inc. Â
Â
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
Clean Hospitals Corner With Alexandra Peters, PhD: The Issues Around Outsourcing
November 7th 2024Outsourcing environmental hygiene in health care facilities offers cost benefits but often compromises quality. Effective oversight, training, and standards are essential for ensuring patient safety.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety